Member Info for F458

Another 7M plus delayed buy showing as a sell. Look out for further late buys

Listen to Podcast today by J Q. £1M contract will shortly be announced followed by many more.
Holiday period over we are now on the case with further contracts. 0.3p -0.5p then 1p
Market Cap is going to re-rate here quickly

shorts getting squeezed

Buyers back in, last few trades are showing as sells.

Image further £15M in the pot, Keeps company active for 3 years. A JV or buyout for Libicore min £35m-£50M which is not included in the current M/C..... 50p plus a share overnight

More like a JV progress for production. OVB did state they wish to become a manufacturer of their product. Having access to £15M plus all helps in them achieving this.

Still can't see several buys from earlier, not showing on ADVFN nor LSE.

Most of the stops taken out this morning by mm's dropping on such small volume. 3.5p down to 2.7p crazy.
They are loading up for positive news, am expecting 5p plus rise now

Markets now waking up to the true value here. £35M plus M/C short term then expect £50M plus on JV or buyout

Thanks for the sellers just bought another 10500 @ 12.25p increasing my stake here.
Sometimes best sit back and hold, but buying opportunities on a share like this a must.
We have £14M of Poly with Dividend payment
Cash in Bank
BP - 101 ( Libicore ) Awaiting a JV or Buyout - £25M - £50M reservedly
= All for £9.9M M/C
Expecting £35M min M/C on next news = 40p plus a share

It's called dilution, A further £1.35M = further 1BN shares. Without all the Legacy issues of which the CEO was aware of but choose not to tell us investors. Before the Name change we were at 0.38p fallen to 0.1p. Even with 3BN worth of shares issued within 6months any contracts will be devalued by the number of shares in Issue.
As to my last post which I still stand by, We investors will be paying for all the debts, Plus once the issues have been totally resolved, There be a consolidation of the number of shares in issues of which the BOD's will get a huge amount for free.
Meanwhile us Investors will continue with dilution. So we have a contract for 2 years worth £1M A YEAR.
Thats all we have for now. Yes the boys will be working hard, But there will be no more mention of any further contracts until the company is completely debt free. I would expect we will drift back to 0.12 - 0.16p so this has become a traders share.
The RNS, Q & A have really told us nothing that we don't already know. other than DS is softening his own negligent behaviour to the bad management of the current Legacy issues.
On the other hand he has done well in getting all investors to pay for a shell company, pay all its debts, get a fresh new name and then release shortly an RNS with a consolidation package that will give him and the directors a huge stake in ICON for free.
This is why the BOD's show no commitment in buying shares, When they get them for free.
So its to the end of the year before all issues resolved then maybe we see some uplift in early 2020. Great Job

We did hear from the horses mouth DS that there are still some debt issues outstanding hence why the additional £1.35M will be needed and converted to further shares being released. He gave a 6 month time period as these may drag on.
Hopefully Q & A will address this further

Nice to see decent buys again,NT on any reasonable size back to 20 p

So read the info from OVB recently placed on their web site. Clearly states third party to produce and clarifies Junipers evolvement through the trail period
From OVB

The drug is produced by contract manufacturing organisations (CMOs). IVIX does not have and does not intend to develop its own manufacturing facilities until significant revenues from sales are achieved. For drug manufacturing, IVIX has chosen CMOs with strong track records of quality assurance and regulatory compliance. In Russia, the drug is manufactured by Nativa LLC, a CMO which has numerous peptide drugs in its portfolio that have been successfully produced for the Russian market.

Juniper Pharma Services, located in Nottingham, UK, will fulfil the second part of the drug manufacturing cycle for IVIX, namely production of the final drug product. Juniper Pharma Services have strong experience in the manufacturing of ready dosage forms for clinical trials, under a Medicines and Healthcare Products Regulatory Agency (MHRA) license.
The glass vials and nasal spray pump for the drug product are manufactured by SGD (France) and Aptar (Germany) respectively, both established firms in their respective areas with strong track records of product quality assurance.

Juniper can find other sources to produce such a large production scale of Libicore. And OVB have stated that they want to expand into production themselves as well as R & D. But their product is tapping into a £BN market and have attracted bigger players whom be interested in buying Libicore and producing themselves.The key here was always getting approval and whilst the Licence is awaiting, We will be expecting third parties come forward with their proposals.

Expecting RNS from OVB confirming JV interested party to produce and distribute Libicore.
Be massive re-rate if Bachem AG confirms they are in discussions and going to either buy the Patent rights for 20 Years or JV
Either way its a win win for OVB.

Bachem AG - a huge Swiss pharma attending IMAP 2019 at the end of August will be mentioning Libicore.

SL
Its making the best out of a bad situation. There can't be many here on profit other than huge losses from 0.3p
As COdey sensibly stated keep a decent stake and ride the wave as EGHO continue to fleece us. Try and play at their games you might be surprised

Nothings changed other than further 6 month delay to sought out all the skeletons.
So they confirmed over 1.65BN shares in issue at present. Release further £1.35 M which EHGO have and can do that even more
shares to forward sell. Really need major contracts to push this above our current crisis.
All one can do is top up on the dip. Back to 0.12p unfortunately as this will be traded now on any rise as we can see

MM's caught out again, dropped on a few sells required for liquidity .